Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Angela Vandelli

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 15, 2014
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transportGiovanni Tosi, Antonietta Vilella, Resham Chhabra, et al.
Pharmaceutics|January 21, 2023
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid NanoparticlesIlaria Ottonelli, Andrea Bighinati, Elisa Adani, et al.
Nanomaterials (Basel, Switzerland)|November 27, 2021
Tween<sup>®</sup> Preserves Enzyme Activity and Stability in PLGA NanoparticlesJason Thomas Duskey, Ilaria Ottonelli, Arianna Rinaldi, et al.
International Journal of Nanomedicine|June 20, 2014
Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopyLorella Pascolo, Barbara Bortot, Nuria Benseny-Cases, et al.
Pharmaceutics|September 28, 2021
Microfluidic Technology for the Production of Hybrid NanomedicinesIlaria Ottonelli, Jason Thomas Duskey, Arianna Rinaldi, et al.
Plos One|May 27, 2016
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage DisordersMarika Salvalaio, Laura Rigon, Daniela Belletti, et al.
International Journal of Pharmaceutics|December 15, 2025
Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patientsAlessandro Anderlini, Manuela Sabelli, Elena Corradini, et al.
International Journal of Pharmaceutics|March 14, 2024
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cellsArianna Rinaldi, Florence Dumas, Jason Thomas Duskey, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 9, 2024
Analysis of phytocannabinoids in hemp seeds, sprouts and microgreensElena Ferri, Fabiana Russo, Maria Angela Vandelli, et al.
Pharmaceutics|July 27, 2022
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer TreatmentsJason Thomas Duskey, Arianna Rinaldi, Ilaria Ottonelli, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 15, 2014
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transportGiovanni Tosi, Antonietta Vilella, Resham Chhabra, et al.
Pharmaceutics|January 21, 2023
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid NanoparticlesIlaria Ottonelli, Andrea Bighinati, Elisa Adani, et al.
Nanomaterials (Basel, Switzerland)|November 27, 2021
Tween<sup>®</sup> Preserves Enzyme Activity and Stability in PLGA NanoparticlesJason Thomas Duskey, Ilaria Ottonelli, Arianna Rinaldi, et al.
International Journal of Nanomedicine|June 20, 2014
Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopyLorella Pascolo, Barbara Bortot, Nuria Benseny-Cases, et al.
Pharmaceutics|September 28, 2021
Microfluidic Technology for the Production of Hybrid NanomedicinesIlaria Ottonelli, Jason Thomas Duskey, Arianna Rinaldi, et al.
Plos One|May 27, 2016
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage DisordersMarika Salvalaio, Laura Rigon, Daniela Belletti, et al.
International Journal of Pharmaceutics|December 15, 2025
Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patientsAlessandro Anderlini, Manuela Sabelli, Elena Corradini, et al.
International Journal of Pharmaceutics|March 14, 2024
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cellsArianna Rinaldi, Florence Dumas, Jason Thomas Duskey, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 9, 2024
Analysis of phytocannabinoids in hemp seeds, sprouts and microgreensElena Ferri, Fabiana Russo, Maria Angela Vandelli, et al.
Pharmaceutics|July 27, 2022
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer TreatmentsJason Thomas Duskey, Arianna Rinaldi, Ilaria Ottonelli, et al.
Pageof 12